BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30503265)

  • 1. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.
    Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM
    Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient desensitization in selected patients with platinum hypersensitivity reactions.
    O'Malley DM; Vetter MH; Cohn DE; Khan A; Hays JL
    Gynecol Oncol; 2017 Jun; 145(3):603-610. PubMed ID: 28410757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
    Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
    Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
    Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
    Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
    Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
    J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
    Schwartz JR; Bandera C; Bradley A; Brard L; Legare R; Granai CO; Dizon DS
    Gynecol Oncol; 2007 Apr; 105(1):81-3. PubMed ID: 17157366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer.
    Abe A; Ikawa H; Ikawa S
    J Med Invest; 2010 Feb; 57(1-2):163-7. PubMed ID: 20299757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of hypersensitivity reaction of platinum in ovarian cancer and cervical cancer patients].
    Li L; Wu M; Yang JX; Wan XR; Huang HF; Pan LY; Shen K; Lang JH; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):825-831. PubMed ID: 27916065
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
    Markman M; Hsieh F; Zanotti K; Webster K; Peterson G; Kulp B; Spicel A; Belinson J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):25-8. PubMed ID: 14564516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
    Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.
    Ottaiano A; Tambaro R; Greggi S; Prato R; Di Maio M; Esposito G; Scala F; Barletta E; Losito S; De Vivo R; Iaffaioli VR; Pignata S
    Anticancer Res; 2003; 23(4):3465-8. PubMed ID: 12926091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
    Kuo JC; Hawkins C; Yip D
    Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rechallenges without desensitization following platinum-based chemotherapy reactions.
    Young FD; Aung S; Tang M; Anstey KM; Lee MC; Alfaro E; Cinar P; Ho H; Otani IM
    J Oncol Pharm Pract; 2024 Apr; 30(3):572-575. PubMed ID: 38347725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and Efficacy of Cisplatin Treatment after Carboplatin Hypersensitivity Reactions in Gynecologic Malignancies].
    Matsuoka N; Yokoyama T; Fujimoto E; Sakai M; Okame S; Shiroyama Y; Yokoyama T; Takehara K
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2091-2095. PubMed ID: 29361624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.